SOPHiA GENETICS (SOPH) Enterprise Value (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of Enterprise Value data on file, last reported at -$70.3 million in Q4 2025.

• For the quarter ending Q4 2025, Enterprise Value rose 12.39% year-over-year to -$70.3 million; the trailing twelve-month figure through Dec 2025 stood at -$70.3 million (up 12.39% YoY), and the FY2025 full-year result was -$70.3 million, up 12.39% from the prior year.
• Enterprise Value grew to -$70.3 million in Q4 2025, from -$81.6 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$64.1 million in Q2 2021 to a low of -$280.6 million in Q3 2021.
• A 5-year average of -$142.4 million and a median of -$123.3 million in 2023 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value slumped 237.75% in 2022 and soared 35.91% in 2024, its largest moves.
• Tracing SOPH's Enterprise Value over 5 years: stood at -$265.3 million in 2021, then jumped by 32.68% to -$178.6 million in 2022, then jumped by 31.0% to -$123.3 million in 2023, then jumped by 34.91% to -$80.2 million in 2024, then advanced by 12.39% to -$70.3 million in 2025.
• Business Quant data shows SOPH's Enterprise Value at -$70.3 million in Q4 2025, -$81.6 million in Q3 2025, and -$94.8 million in Q2 2025.